Paper Details

  1. Home
  2. Paper Details

Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.

Author: MartinGeorge M, StockflethEggert

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Diclofenac sodium 3% gel (Solaraze®) has been used to treat actinic keratosis (AK) for more than 10 years.
Paper Details　
Original Abstract of the Article :
Diclofenac sodium 3% gel (Solaraze®) gained US approval for the treatment of actinic keratosis (AK) more than 10 years ago. Since the publication of the pivotal phase 3 studies, numerous clinical studies have assessed use of this therapy in a variety of body areas, special populations, and novel com...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/22527428

データ提供：米国国立医学図書館（NLM）

Diclofenac Sodium 3% Gel for Actinic Keratosis: Long-Term Evidence

Actinic keratosis (AK) is a common precancerous skin condition that requires careful management. This research explores the long-term efficacy and safety of diclofenac sodium 3% gel in treating AK. The study compiles over a decade of clinical evidence to assess the effectiveness of this therapy in various populations and treatment scenarios.

Proven Efficacy and Safety: A Decade of Evidence

The review of numerous clinical studies confirmed the effectiveness and safety of diclofenac sodium 3% gel in treating AK. The gel has been successfully used in a variety of body areas, special populations, and even in novel combinations. This extensive body of evidence reinforces the value of diclofenac sodium 3% gel as a reliable and effective treatment option for AK.

Navigating Skin Health: A Clear Path for Actinic Keratosis

This research provides reassurance about the long-term safety and effectiveness of diclofenac sodium 3% gel for treating AK. The compilation of data from multiple studies demonstrates its versatility and reliability in various settings. It's like finding a well-marked path through the desert of AK treatment options, providing clear guidance for healthcare professionals and patients.

Dr.Camel's Conclusion

Actinic keratosis can be a concerning skin condition. This review provides a comprehensive overview of the extensive evidence supporting the safety and efficacy of diclofenac sodium 3% gel in managing AK. It's like finding a reliable oasis in the desert of treatment options, offering a clear path toward effective and safe management of this condition.

Date :
  1. Date Completed 2012-08-15
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

22527428

DOI: Digital Object Identifier

22527428

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.